**Question:** All of the following are true for patients of ulcerative colitis associated with primary sclerosing cholangitis (PSC), EXCEPT:

A. Increased risk of cholangiocarcinoma
B. More severe colitis compared to isolated ulcerative colitis
C. Unchanged liver function tests
D. Lower incidence of primary sclerosing cholangitis

**Core Concept:**

Primary sclerosing cholangitis (PSC) is a cholestatic liver disease characterized by inflammatory destruction of the bile ducts, leading to fibrosis and eventually, obliterative cholangiopathy. PSC is often associated with inflammatory bowel diseases, such as ulcerative colitis (UC). UC is a type of inflammatory bowel disease (IBD) that primarily affects the large intestine (colon and rectum). IBD can also be associated with other IBDs or other medical conditions.

**Why the Correct Answer is Right:**

The correct answer, option D (Lower incidence of primary sclerosing cholangitis), is right because primary sclerosing cholangitis is more commonly associated with ulcerative colitis (option A), Crohn's disease (not mentioned in the question), and primary sclerosing cholangitis itself (option C). The correct answer is not related to the severity of ulcerative colitis (option B) or liver function tests (option C). This is because the question focuses on the association between primary sclerosing cholangitis and ulcerative colitis, not their severity or liver function.

**Why Each Wrong Option is Incorrect:**

Option A (Increased risk of cholangiocarcinoma) is incorrect because primary sclerosing cholangitis itself is not the cause of cholangiocarcinoma. Cholangiocarcinoma is associated with long-standing PSC, especially when complicated by choledocholithiasis or bile duct strictures. In such cases, the risk of cholangiocarcinoma increases significantly.

Option B (More severe colitis) is incorrect because the severity of ulcerative colitis is not relevant to the association between primary sclerosing cholangitis and ulcerative colitis. The severity of UC does not dictate the occurrence of PSC. Instead, the association is based on the presence of PSC in patients with UC.

Option C (Unchanged liver function tests) is incorrect because liver function tests can be abnormal in patients with PSC, despite having UC. The cholestatic liver enzymes (such as alkaline phosphatase, gamma-glutamyl transaminase, and alkaline phosphatase) are usually normal or only mildly elevated in PSC. Altered liver function tests are more likely in patients with associated liver diseases or cholestasis due to biliary obstruction (like choledocholithiasis) rather than the presence of PSC itself.

**Clinical Pearl:**

In patients with PSC and UC, clinicians should stay vigilant for signs of choledocholithiasis or biliary obstruction, which can lead to cholestasis and abnormal liver function tests, despite having normal or mildly elevated liver enzymes in PSC itself. Early recognition and management of cholestasis can prevent complications like cholangitis, liver abs